778
A. Petz et al. / Steroids 67 (2002) 777–781
2.1. General procedure for the synthesis of steroidal
formyl derivatives
C, 75.71; H, 9.03; N, 4.65; Found: C, 75.49; H, 9.31;
N, 4.33.
2.2.4. 17-Formyl-3-methoxy-estra-1,3,5(10),16-tetraene (9)
1H NMR (CDCl3, 400 MHz): 9.73 (s, 1H, CHO); 6.70
(d, 8.4 Hz, 1H, 1-CH); 7.19 (dd, 3.2 Hz, 8.4 Hz, 1H, 2-CH);
6.81 (dd, 2.0 Hz, 3.6 Hz, 1H, 16-CH); 6.62 (d, 3.2 Hz, 1H,
4-CH); 3.76 (s, 3H, OCH3); 2.86 (m, 2H, 6-CH2); 2.3
(m, 4H; skeleton protons); 2.05 (ddd, 1H, 15-HaHb); 1.9
(m, 1H, 15-HaHb); 1.6 (m, 4H; skeleton protons); 1.4 (m,
1H; skeleton proton); 0.96 (s, 3H, 18-CH3); MS (m/z/rel.
int.): 296/100 (M+); 173/50; 160/62. Analysis calculated
for C20H24O2 (M = 296.41): C, 81.04; H, 8.16; Found: C,
80.83; H, 8.40.
A mixture of an ‘iodo-vinyl’ derivative (1 mmol), palla-
dium(II) acetate (11.2 mg, 0.05 mmol), and triphenylphos-
phine (26.2 mg, 0.1 mmol) (or 1,4-bis(diphenylphosphino)-
butane (dppb), 1,3-bis(diphenylphosphino)-propane (dppp)
0.05 mmol)) were dissolved in 14 ml toluene under argon.
The atmosphere was changed to carbon monoxide (1 bar),
then tributyltin hydride (0.32 ml, 1.2 mmol) dissolved in
3 ml toluene was added dropwise to the reaction mixture at
50 ◦C in 2 h. The reaction was conducted for an additional
6 h. (The composition of the reaction mixture was checked
by TLC and determined by GC-MS.) The solvent was evap-
orated to dryness, and the rest was dissolved in 10 ml of
chloroform. Potassium fluoride (0.2 g) dissolved in 10 ml
water was added and stirred vigorously for 10 h. The organic
layer was separated, dried on sodium sulfate and evapo-
rated. The chromatography (silicagel, toluene/methanol =
4/1) resulted in the formyl-products in 50–75% isolated
yields.
2.2.5. 17-Formyl-6b-hydroxy-3a,5a-cycloandrost-
16-ene (10)
1H NMR (CDCl3, 400 MHz): 9.73 (s, 1H, CHO); 6.80
(dd, 2.0 Hz, 3.4 Hz, 1H, 16-CH); 4.30 (m, 1H, 6-H); 3.3 (t,
1H, 6-OH); 2.20–0.80 (16H; skeleton protons); 1.10 (s, 3H,
18-CH3); 0.97 (s, 3H, 19-CH3); 0.54 (t, 6.5 Hz, 1H, 3-CH);
0.30 (dd, 6 Hz, 11 Hz, 1H, 4-Ha); MS (m/z/rel. int.): 282/55
(M+–H2O); 267/30 ((M+–H2O–CH3); 145/65; 121/100.
Analysis calculated for C20H28O2 (M = 300.44): C, 79.96;
H, 9.39; Found: C, 79.71; H, 9.15.
2.2. Analytical and spectroscopic data of compounds
2.2.1. 17-Formyl-androst-16-ene (6)
1H NMR (CDCl3, 400 MHz): 9.68 (s, 1H, CHO); 6.76
(dd, 1.7 Hz, 3.4 Hz, 1H, 16-CH); 2.34 (ddd, 3.4 Hz, 6.4 Hz,
17.5 Hz, 1H, 15-CHaHb); 2.04 (ddd, 1.7 Hz, 11.9 Hz,
17.5 Hz, 1H, 15-CHaHb); 0.88 (s, 3H, 18-CH3); 0.80 (s, 3H,
19-CH3); 13C NMR (100.58 MHz, CDCl3): 190.1 (CHO);
157.2 (17-C); 153.1 (16-C); 56.6; 55.4; 47.5; 47.2; 38.5;
36.5; 34.4; 33.8; 32.7; 32.1; 29.1; 28.9; 26.8; 22.0; 20.6;
13.6 (18-CH3); 12.2 (19-CH3); MS (m/z/rel. int.): 286/62
(M+); 271/40 (M+–CH3); 257/90 (M+–CHO), 189/100.
Analysis calculated for C20H30O (M = 286.46): C, 83.86;
H, 10.56; Found: C, 83.58; H, 10.28.
2.3. MS data for the side-products (m/z/rel. int.)
2.3.1. Androst-16-ene (1a)
258/46 (M+); 243/100 (M+–CH3); 148/72; 94/86; re-
tention time (RT, under GC conditions specified above):
9.7 min.
2.3.2. Androst-15-ene (1b)
258/69 (M+); 243/45 (M+–CH3); 148/70; 94/100; RT:
10.8 min.
2.2.2. 17-Formyl-4-aza-4-methyl-androst-16-en-3-one (7)
1H NMR (CDCl3, 400 MHz): 9.69 (s, 1H, CHO); 6.77
(dd, 1.6 Hz, 3.2 Hz, 1H, 16-CH); 3.03 (m, 1H, 5-CH); 2.91
(s, 3H, N-CH3); 1.2–2.5 (m, 17H, ring protons); 1.05 (s,
3H, 18-CH3); 0.89 (s, 3H, 19-CH3). MS (m/z/rel. int.):
315/66 (M+); 300/12 (M+–CH3); 286/22 (M+–CHO);
70/100. Analysis calculated for C20H29NO2 (M = 315.46):
C, 76.15; H, 9.27; N, 4.44; Found: C, 75.90; H, 9.02;
N, 4.26.
2.3.3. 4-Aza-4-methyl-androst-16-en-3-one (2a)
287/80 (M+); 272/45 (M+–CH3); 124/50; 70/100; RT:
14.4 min.
2.3.4. 4-Aza-4-methyl-androst-15-en-3-one (2b)
287/52 (M+); 272/5 (M+–CH3); 112/100; 70/41; RT:
14.9 min.
2.3.5. 4-Aza-androst-16-en-3-one (3a)
273/82 (M+); 258/100 (M+–CH3); 147/70; 91/96; RT:
14.3 min.
2.2.3. 17-Formyl-4-aza-androst-16-en-3-one (8)
1H NMR (CDCl3, 400 MHz): 9.60 (s, 1H, CHO);
6.70 (dd, 1.7 Hz, 3.4 Hz, 1H, 16-CH); 6.4 (brs, 1H,
NH); 3.06 (dd, 4.4 Hz, 11.6 Hz, 1H, 5-CH); 2.40 (m,
2H, 2-CH2); 2.10 (ddd, 1H, 15-CHaHb); 1.95 (ddd, 1H,
15-CHbHb); 1.80–0.80 (13H; skeleton protons); 0.99 (s,
3H, 18-CH3); 0.94 (s, 3H, 19-CH3); MS (m/z/rel. int.):
301/60 (M+); 286/38 (M+–CH3); 272/51 (M+–CHO);
56/100. Analysis calculated for C19H27NO2 (M = 301.43):
2.3.6. 4-Aza-androst-15-en-3-one (3b)
273/100 (M+); 258/53 (M+–CH3); 180/55; 98/76; RT:
14.9 min.
2.3.7. 3-Methoxy-estra-1,3,5(10),16-tetraene (4a)
268/100 (M+); 253/20 (M+–CH3); 173/56; 147/40; RT:
15.2 min.